Search for Clinical Trial Results

Familial Primary Pulmonary Hypertension - 25 Studies Found
Status | Study |
Recruiting |
Study Name: National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2013-07-08 |
Recruiting |
Study Name: Hormonal, Metabolic, and Signaling Interactions in PAH Condition:
|
Recruiting |
Study Name: Efficacy Study of Cardizem in Pulmonary Arterial Hypertension Condition:
|
Not yet recruiting |
Study Name: A Mobile Health Intervention in Pulmonary Arterial Hypertension Condition:
|
Not yet recruiting |
Study Name: ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy Condition: Pulmonary Arterial Hypertension (PAH) Date: 2017-05-02 Interventions:
|
Recruiting |
Study Name: Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2017-04-04 Interventions: Procedure: Patients with Pulmonary Arterial Hypertension 2 repeated measurement session to enable assess |
Not yet recruiting |
Study Name: Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. Condition: Pulmonary Arterial Hypertension Date: 2017-03-06 Interventions:
|
Recruiting |
Study Name: Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2016-05-04 Interventions: Drug: Anakinra Other Name: Kineret |
Completed |
Study Name: TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Arterial Hypertension Date: 2017-02-09 Interventions: Drug: Remodulin® (Intravenous Treprostinil) Intravenous treprostinil supplied in 20-mL vials and di |
Not yet recruiting |
Study Name: Impact of Rehabilitation Program on PAH Patients Treated With Macitentan. Condition: Pulmonary Arterial Hypertension Date: 2017-02-05 Interventions: Other: Exercise program patients who are stable on Macitentan therapy (received in both groups before en |